References
Bani-Sadr et al (2020). Corticosteroid therapy for patients with COVID-19 pneumonia: a before–after study. International Journal of Antimicrobial Agents, 56(2), 106077.
Gong et al (2020). Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old. Journal of medical virology, 92(11), 2551-2555.
Hu et al (2020). Clinical use of short-course and low-dose corticosteroids in patients with non-severe COVID-19 during pneumonia progression. Frontiers in public health, 8, 355.
Li and Ma (2020). Acute respiratory failure in COVID-19: is it “typical” ARDS?. Critical Care, 24, 1-5.
Li et al (2020). Efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe COVID-19 pneumonia: a retrospective cohort study. Infectious diseases and therapy, 9(4), 823-836.
Liu et al (2020). Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. Journal of Infection, 81(1), e95-e97.
Mazza et al (2020). A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis. Gut, 69(6), 1148-1149.
Saghazadeh and Rezaei (2020). Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. International immunopharmacology, 106560.
Singh et al (2020). Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 971-978.
Su et al (2020). Tailoring steroids in the treatment of COVID-19 pneumonia assisted by CT scans: three case reports. Journal of X-ray science and technology, (Preprint), 1-8.
Wang et al (2020). Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. MedRxiv.
Yuan et al (2020). Effects of corticosteroid treatment for non-severe COVID-19 pneumonia: a propensity score-based analysis. Shock, 54(5), 638-643.
Zha et al (2020). Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Medical Journal of Australia, 212(9), 416-420.
Zhai et al (2020). The epidemiology, diagnosis and treatment of COVID-19. International journal of antimicrobial agents, 55(5), 105955.